Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel
Open Access
- 1 January 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 15 (6), 242
- https://doi.org/10.1186/cc10498
Abstract
In June 2011 the Canadian National Advisory Committee on Blood and Blood Products sponsored an international consensus conference on transfusion and trauma. A panel of 10 experts and two external advisors reviewed the current medical literature and information presented at the conference by invited international speakers and attendees. The Consensus Panel addressed six specific questions on the topic of blood transfusion in trauma. The questions focused on: ratio-based blood resuscitation in trauma patients; the impact of survivorship bias in current research conclusions; the value of nonplasma coagulation products; the role of protocols for delivery of urgent transfusion; the merits of traditional laboratory monitoring compared with measures of clot viscoelasticity; and opportunities for future research. Key findings include a lack of evidence to support the use of 1:1:1 blood component ratios as the standard of care, the importance of early use of tranexamic acid, the expected value of an organized response plan, and the recommendation for an integrated approach that includes antifibrinolytics, rapid release of red blood cells, and a foundation ratio of blood components adjusted by results from either traditional coagulation tests or clot viscoelasticity or both. The present report is intended to provide guidance to practitioners, hospitals, and policy-makers.This publication has 85 references indexed in Scilit:
- The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy frameworkTransfusion Medicine, 2012
- The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trialThe Lancet, 2011
- The effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction scoreVox Sanguinis, 2011
- The acute management of trauma hemorrhage: a systematic review of randomized controlled trialsCritical Care, 2011
- Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapyCritical Care, 2011
- Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialThe Lancet, 2010
- Clinical review: Fresh frozen plasma in massive bleedings - more questions than answersCritical Care, 2010
- Prior Antiplatelet Therapy, Platelet Infusion Therapy, and Outcome after Intracerebral HemorrhageJournal of Stroke and Cerebrovascular Diseases, 2009
- The Relationship of Blood Product Ratio to Mortality: Survival Benefit or Survival Bias?The Journal of Trauma and Acute Care Surgery, 2009
- Thrombelastography and tromboelastometry in assessing coagulopathy in traumaScandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2009